























 |
Immunology 101 & 102- Definitions and Terms
The following definitions are provided to help
lay people and Veterinarians like me, who graduated 27 years ago and did not
have a course in immunology, to understand the new principals of
vaccination.
Adjuvant
 |
a
nonspecific stimulator of the immune system, incorporated into a vaccine
to increase the immune response. Adjuvant combines with the antigen to
slow the release, causing a prolonged, and stronger immune response. It
also increases the immune response by causing increased inflammation
|
 |
The
make-up of the adjuvant is generally a closely guarded proprietary secret
of the vaccine manufacturers. Many adjuvants are aluminum containing
compounds.
|
 |
Killed
vaccines (Rabies, Killed PLP) some sub-unit vaccines (FeLV) and even some
MLV Vaccines (FIV) require adjuvant in order to produce an effective
immune response.
|
 |
Adjuvanted vaccines are at higher risk of adverse reactions and adverse
events such as vaccine associated fibrosarcomas.
Antibody
|
 |
a
molecule produced by plasma cells, which interacts with it’s specific
antigen, to destroy or stimulate destruction of the antigen by
macrophages. Antibodies are specific for the antigen they are produced to
reject.
|
 |
Antibodies are
classified according to the mode of immune response they are specialized
for.
Ex. IgM = early systemic, IgG= late systemic, IgA = surface, IgE =
allergic.
Antigen |
 |
a substance the body
recognizes as foreign and reacts with specific antibody production to
reject.
Ex. bacteria, virus, protozoa, parasite, pollen, toxin or cell.
Cellular Immunity
(cell mediated immunity) |
 |
Immunity
mediated by T lymphocytes, or an immune response where phagocytic cells
play the predominate role. |
 |
Immunity directed
against a cell that is infected with a foreign organism like a virus. This
is more effective then humoral immunity or antibodies, as it prevents
replication of the virus. |
 |
Cellular immunity
cannot be readily measured. It can be demonstrated by challenge studies.
|
|
|
|
Challenge study
– In order to assess the effectiveness
of a vaccine,
-
One group of animals is designated as
controls and is not vaccinated.
- A second group of
animals is vaccinated.
- All animals are
challenged by exposure to the disease organism they were vaccinated
against.
- The percentage of
animals protected is determined. This is called the protective fraction.
 | Although challenge studies cannot be
done on human subjects, in Veterinary Medicine this is considered the gold
standard to test the efficacy of a vaccine. Human vaccines must rely on
titers to indicate efficacy.
Clades
|
 |
categories by
which viruses are subdivided. Related but not identical groups. Cross
protection by vaccines between viruses of different Clades is poor.
|
Humoral Immunity –
immunity provided by antibodies.
Koch’s Postulates
– the evidence required to
scientifically prove
that an organism is the cause
of a specific disease.
1.
The organism must be present every time a specific set of
symptoms are present.
2. The
organism must be isolated, when the disease is
present.
3.
The disease must be reproduced by infection of
animals with
the agent.
4. The
organism must be recovered from the diseased animal.
*Results must be reproducible.
 |
Ex.
Canine Corona virus has never satisfied Koch’s postulates in adult
dogs, nor has it ever been demonstrated to be a cause of disease in dogs
over 8 weeks of age
|
Memory cells
 |
B & T
lymphocytes. Once programmed to produce antibodies, memory cells retain
the information and persist for the life of the animal. |
 |
Systemic memory
cells can respond with antibody production, fast enough to prevent
infection or prevent disease, even in the absence of an antibody titer. |
 |
Mucosal memory
cells cannot respond quickly enough to prevent infection, but respond
quickly to minimize the symptoms, and hopefully provide for a lesser
degree of illness. |
 |
Memory cells cannot be
readily measured. The only way to demonstrate memory cells is with a
challenge study |
Temporal Association
 |
An event that appears
related to a result, more often than would be expected by mere chance. It
does not necessarily prove cause and effect. |
 |
An example often
referred to by scientists is: “ Butter keeps elephants out of the
refrigerator. “ At first the correlation of these two events might appear
to be a valid observation. Certainly we have butter in our refrigerators,
and we have no elephants in our refrigerators. However, is butter really
the cause? With further investigation we may or may not find out that
refrigerators without butter have no elephants either. And or we may find
out that something else is keeping the elephants out of the refrigerator.
Or we might find out that elephants are affected by the butter in such a
way that they stay out of the refrigerators solely because of the butter,
or in combination with another cause. |
 |
We must be careful in
drawing conclusions based on temporal associations because our conclusions
may or may not be correct. |
A temporal association
merely implies that further investigation is warranted and may be necessary to prove cause
and effect.
 | If you understand
this you are now thinking like a scientist, and you no longer have a
personality or a life. |
 | If you don’t
understand this, ask Dr. Seus. |
Serovars
 |
categories by which
bacteria are subdivided or classified. Cross protection between bacteria
of different serovars is poor. |
Titer
 |
a
measure of the quantity of antibodies. The amount of antibodies required
to neutralize a measured amount of antigen, expressed as the highest
dilution required for neutralization. Ex 1:10, 1:160 |
 |
A high titer
is a rough correlation with immunity for some diseases. |
 |
A negative
titer does not necessarily indicate lack of
immunity, as immunity is also controlled by cellular immunity, memory
cells, which can respond with antibody production when needed.
|
 |
Titers do not
measure or take into account memory cells or cellular immunity. |
Vaccine
 |
a biologic agent
containing antigens, live organisms, or killed organisms, or DNA, which
will stimulate the immune system of the patient to produce antibodies, and
possibly cellular immunity, as well as program memory cells to provide
protection against disease. A vaccine does not provide immunity; it merely
stimulates the body to produce immunity. A vaccine depends on the body’s
response to provide protection. |
Types of vaccines:
 |
Killed
vaccines –(Inactivated) for safety, to
prevent reversion to virulence, the organism is killed. Adjuvants are
generally required to stimulate a sufficient immune response. Depending on
the antigen and adjuvant, they may or may not produce cellular immunity.
Duration of immunity is generally not as long as with modified live
vaccines. Examples: Rabies, Leptospirosis, and Bordetella.
|
 |
Modified
live virus vaccines –(Attenuated) the
virus has been weakened or attenuated so that it should not produce the
disease. MLV vaccines produce strong stimulation of the immune system
because they reproduce or replicate within the host cells, providing for
even more antigen. Adjuvant is generally not needed. Because the vaccine
virus reproduces within the host cells, MLV vaccines produce cellular
immunity. This immunity is directed toward future cells that become
infected with the virus. This is good because it prevents any invading
virus from replicating.
Duration of immunity is generally longer for MLV vaccines.
Although any vaccine can cause a fibrosarcoma, because MLV vaccines do not
have adjuvant they are less likely to cause a fibrosarcoma.
|
 |
Subunit
vaccine – a piece of DNA has been
removed form the virus so it is not a whole virus vaccine. This DNA will
still stimulate the immune system to provide immunity against that virus
Ex: Feline leukemia vaccine – the part of the virus that suppresses the
immune system has been removed.
Most FeLV vaccines are adjuvanted. Two manufacturers, Meriel- Leukat, and
Intervet Protex FeLV vaccines are non –adjuvanted.
|
 |
Subunit
vectored vaccines – Purevac Rabies Vaccine,
Muriel - a piece of rabies DNA is spliced onto a canary pox virus. The
canary pox virus does not cause disease in the cat. The canary pox virus
will enable the antigen to be presented to the immune system in such a way
that good cellular immunity is produced without the need for an adjuvant.
This non-adjuvanted vaccine was developed because adjuvanted rabies
vaccines are more likely to cause fibrosarcomas. MLV rabies vaccines were
removed from the market because if administered to a FeLV infected cat
they could revert to virulence and cause rabies. This vaccine cannot
revert to virulence, it cannot possibly cause rabies.
Adjuvanted rabies vaccines have been incriminated in causing thousands of
fibrosarcomas over the last 10 years. Only two fibrosarcomas are thought
to have been caused by this new subunit vectored vaccine.
|
|